JAMA Psychiatry

Article	Citations
Magnetic Seizure Therapy vs Electroconvulsive Therapy for Major Depressive Episode	743
Error in Results	523
Further Considerations on Early Intervention for Borderline Personality Disorder—Reply	442
Combination Antidepressant Therapy vs Monotherapy—Further Considerations	396
Potential Limitations for Assessing Adverse Posttraumatic Neuropsychiatric Sequelae With Wrist-Wearable Device and Self-report Survey	344
Assumptions and Limitations of the Synthetic Control Method	297
Diagnosing and Treating ADHD in Adults	245
Managerial and Organizational Challenges in the Age of AI	242
TikTok Challenges—Unintentional Injuries vs Suicide Attempts	228
An Opportunity to Advance Cannabis Science—DEA Rescheduling	206
JAMA Psychiatry	203
The Reliability of Traumatic and Adverse Experiences	196
Potential Lessons for DSM From Contemporary Philosophy of Science	191
Left Ventrolateral Prefrontal Cortical Activity During Reward Expectancy and Mania Risk	189
Association Between Genetic Risk for Psychiatric Disorders and the Probability of Living in Urban Settings	181
Race and Ethnicity of Editorial Board Members and Editors as an Indicator of Structural Racism in Psychiatry and Neuroscience Journals	178
Social Vulnerability and Prevalence and Treatment for Mental Health and Substance Use Disorders	176
Neighborhood Disadvantage and Autism Spectrum Disorder in a Population With Health Insurance	174
Consistency of Delusion Themes Across First and Subsequent Episodes of Psychosis	163
Association of Comorbid Behavioral and Medical Conditions With Cannabis Use Disorder in Pregnancy	151
Accelerated Theta-Burst Stimulation for Treatment-Resistant Depression	151
Issues in Clinical Trial Design—Lessons From the FDA’s Rejection of MDMA	148
Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder	141
Effect of Culturally Tailored, Internet-Delivered Cognitive Behavioral Therapy for Insomnia in Black Women	141
Associations Between Neuropsychiatric Symptoms and Neuropathological Diagnoses of Alzheimer Disease and Related Dementias	136

Methamphetamine Use, Methamphetamine Use Disorder, and Associated Overdose Deaths Among US Adults	133
Associations Between Objective and Subjective Experiences of Childhood Maltreatment and the Course of Emotional Disorders in Adulthood	129
JAMA Psychiatry	127
Effect of a Tobacco Cessation Intervention Incorporating Weight Management for Adults With Serious Mental Illness	124
JAMA Network Call for Papers on Health and the 2024 US Election	113
Living Alone and Drug Overdose Deaths in the US	110
Errors in Figures 1 and 2	106
Error in the Caption of Figures 2, 3, 4, and 5 and in Supplement 1	106
JAMA Psychiatry	105
Searching the Brain for the Cause of Psychosis	104
Addiction Medicine Physicians and Medicinal Cannabinoids	104
US Veterans Affairs and Department of Defense 2023 Clinical Guideline for PTSD—Devolving Not Evolving	103
Hyperalgesia in Patients With a History of Opioid Use Disorder	101
Efficacy of Augmentation of Cognitive Behavioral Therapy With Transcranial Direct Current Stimulation for Depression	100
Mental Health Impairment and Outpatient Mental Health Care of US Children and Adolescents	96
Risk for Mood, Anxiety, and Psychotic Disorders in Individuals at High and Low Genetic Liability for Bipolar Disorder and Major Depression	95
Association of Frailty With Risk of Suicide Attempt in a National Cohort of US Veterans Aged 65 Years or Older	94
Perinatal Mental Health Outcomes Following Natural Disasters	93
Error in Byline	91
Evaluation of Post–COVID-19 Cognitive Dysfunction: Recommendations for Researchers	88
Role of Polygenic Risk Score in the Familial Transmission of Bipolar Disorder in Youth	86
Serotonin 4 Receptor Brain Binding in Major Depressive Disorder and Association With Memory Dysfunction	84
JAMA Psychiatry	84
COVID-19 and Mental Health in Young People—Causality or Co-occurrence?	83
Associating Violence With Schizophrenia—Risks and Biases—Reply	83
JAMA Psychiatry—The Year in Review, 2021	83
Etiologic Studies of Premenstrual Disorders Require Prospective Confirmation of Affective Cyclicity	82
Expanding Current Approaches to Solve the Opioid Crisis	81
Errors in Figures 3, 4, and 5	81
War Exposure and DNA Methylation in Syrian Refugee Children and Adolescents	81
Trends in Outpatient Psychotherapy Among Adults in the US	80
Comorbidity and Coaggregation of Major Depressive Disorder and Bipolar Disorder and Cannabis Use Disorder in a Controlled Family Study	79
Combination Antidepressant Therapy vs Monotherapy—Further Considerations	77
Limitations for Assessing Optimism and Physical Functioning in Women—Reply	76
Implementation Strategies Used and Reported in Brief Suicide Prevention Intervention Studies	73
JAMA Psychiatry	73
Does Vaccination Really Mitigate Psychiatric Implications of COVID-19?—Reply	72
Psychosis Spectrum Symptoms Before and After Adolescent Cannabis Use Initiation	71
Physician Suicide and Associated Features—What Defines a Physician?	70
Evaluation of a Model to Target High-risk Psychiatric Inpatients for an Intensive Postdischarge Suicide Prevention Intervention	70
Adjuvant Psychotherapies to Prevent Relapse in Bipolar Disorder	69
Sweetened Beverages and Incident All-Cause Dementia Among Older Adults	68
Genetic Liabilities Differentiating Bipolar Disorder, Schizophrenia, and Major Depressive Disorder, and Phenotypic Heterogeneity in Bipolar Disorder	66
Neurobiological, Psychosocial, and Behavioral Mechanisms Mediating Associations Between Physical Activity and Psychiatric Symptoms in Youth in the Netherlands	65
Stratified Care vs Stepped Care for Depression	65
Metabolomic Biomarker Signatures for Bipolar and Unipolar Depression	64
Errors in Text, Tables, and Figure	64
Social Determinants of Health and Suicide-Related Outcomes	64
Methadone-Involved Overdose Deaths in the US Before and After Federal Policy Changes Expanding Take-Home Methadone Doses From Opioid Treatment Programs	64
Error in Figure 2	63

Reducing the Risks of Nuclear War	63
Suicide Risk—A Specific Intervention Target	63
Errors in Author Affiliations, Table, and Figure 3	63
Do Not Rule Out Double-blind Placebo Run-in Periods for Randomized Clinical Trials	63
Etiologic Studies of Premenstrual Disorders Require Prospective Confirmation of Affective Cyclicity—Reply	62
Loss of PTSD Diagnosis in Response to Evidence-Based Treatments	61
Association of Ambient Temperature With the Prevalence of Intimate Partner Violence Among Partnered Women in Low- and Middle-Income South Asian Countries	60
Psychomotor Slowing in Psychosis and Inhibitory Repetitive Transcranial Magnetic Stimulation	59
Right-Based Mental Health Care—Advantages of Tax-Financed Universal Mental Health Care	59
Bright Light Therapy as Add-On to Inpatient Treatment in Youth With Moderate to Severe Depression	59
Assessment of Disruptive Life Events for Individuals Diagnosed With Schizophrenia or Bipolar I Disorder Using Data From a Consumer Credit Reporting Agency	59
Brexpiprazole and Sertraline Combination Treatment in Posttraumatic Stress Disorder	59
Written Exposure Therapy Finds Solid Footing Alongside First-Line Psychotherapies for Posttraumatic Stress Disorder	58
Hospitalization Associated With Comorbid Psychiatric and Substance Use Disorders Among Adults With COVID-19 Treated in US Emergency Departments From April 2020 to August 2021	58
Emotional Experience of People With Schizophrenia and People at Risk for Psychosis	57
Ultrarare Coding Variants and Cognitive Function in Schizophrenia	57
Efficacy and Cost-Benefit of Onsite Contraceptive Services With and Without Incentives Among Women With Opioid Use Disorder at High Risk for Unintended Pregnancy	55
Baseline Antipsychotic Dose and Transition to Psychosis in Individuals at Clinical High Risk	54
Rural and Urban Trends in Mental Health Readmissions	54
Racial and Ethnic Disparities in Buprenorphine Treatment Duration in the US	54
Association of Racial Discrimination With Neural Response to Threat in Black Women in the US Exposed to Trauma	53
The Need for Functional Assessments in School-Based Mental Health Intervention Research	52
The Rapid Rise in Investment in Psychedelics—Cart Before the Horse	52
Treating Bipolar Depression Using Psilocybin—Validity Threats Regarding Efficacy and Safety	52
Association of Receipt of Opioid Use Disorder–Related Telehealth Services and Medications for Opioid Use Disorder With Fatal Drug Overdoses Among Medicare Beneficiaries Before and During the COVID-19	51
All-Cause and Cause-Specific Mortality Among Individuals With Hypochondriasis	51
Adverse Childhood Experiences and Mental Distress Among US Adults by Sexual Orientation	51
Association Between Failures in Perceptual Updating and the Severity of Psychosis in Schizophrenia	51
Genetic and Phenotypic Features of Schizophrenia in the UK Biobank	49
Lifetime Suicide Attempts in Otherwise Psychiatrically Healthy Individuals	49
Brief Cognitive Behavioral Therapy for Suicidal Inpatients	49
Cognitive Behavior Therapy for Mental Disorders in Adults	49
A Case for Permanent Adoption of Expanded Telehealth Services and Prescribing Flexibilities for Opioid Use Disorder	48
Suicide Risk in Medicare Patients With Schizophrenia Across the Life Span	48
JAMA Psychiatry	48
Prospective and Retrospective Measures of Child Maltreatment and Their Association With Psychopathology	48
Sex Differences in Autism Heritability and Likelihood	47
Errors in Results and Tables	46
The Course of General Cognitive Ability in Individuals With Psychotic Disorders	46
Time to Treat the Climate and Nature Crisis as One Indivisible Global Health Emergency	46
Error in Title of Figure 1	46
Errors in Byline and Abstract	46
Acupuncture for Combat-Related Posttraumatic Stress Disorder	45
Preexisting Neuropsychiatric Conditions and Associated Risk of Severe COVID-19 Infection and Other Acute Respiratory Infections	44
Toward 90-90-90 Goals for Global Mental Health	44
Effect of General Practitioner Training in a Collaborative Child Mental Health Care Program on Children’s Mental Health Outcomes in a Low-Resource Setting	44
Normative Modeling of Brain Morphometry in Clinical High Risk for Psychosis	44
Studying Harms Is Key to Improving Psychedelic-Assisted Therapy—Participants Call for Changes to Research Landscape	44
Physician Suicide and Associated Features—What Defines a Physician?—Reply	43
VA/Department of Defense Clinical Practice Guideline for PTSD and ASD	43
Integrated Nicotine Replacement and Behavioral Support to Reduce Smoking in Opioid Agonist Therapy	43
Suicidal Ideation and Suicide Attempts After Direct or Indirect Psychotherapy	42
Genetic Liability to Posttraumatic Stress Disorder Symptoms and Its Association With Cardiometabolic and Respiratory Outcomes	42
Transdisciplinary Science and Research Training in Psychiatry	42
Functional vs Structural Cortical Deficit Pattern Biomarkers for Major Depressive Disorder	42
JAMA Psychiatry—The Year in Review 2024	42
JAMA Psychiatry	41
Striatal Activity to Reward Anticipation as a Moderator of the Association Between Early Behavioral Inhibition and Changes in Anxiety and Depressive Symptoms From Adolescence to Adulthood	41
Considerations Regarding Antipsychotic Drug Prescriptions Among People With Dementia During the COVID-19 Pandemic	40
Challenges to Behavioral Health and Injury Surveillance During the COVID-19 Pandemic	40
Characterizing Heterogeneity in Neuroimaging, Cognition, Clinical Symptoms, and Genetics Among Patients With Late-Life Depression	40
Antipsychotic Monotherapy vs Polytherapy for Pneumonia Risk—Reply	39
Combination Antidepressant Therapy vs Monotherapy—Further Considerations—Reply	39
Complex Interaction of Lithium With Kidney and Bone Health	39
Psilocybin in Bipolar II Study Provides Preliminary Data on Safety	38
Error in Figure 1	38
Associations Between Early Life Adversity, Reproduction-Oriented Life Strategy, and Borderline Personality Disorder	38
Potential of Control Conditions for Nonspecific Treatment-Effects in Noninferiority Trials—Reply	38
JAMA Psychiatry	38
Prescription Stimulant Prescribing, Nonmedical Use, and Shortages	38
Informant Effect on Placebo Response in Mental Disorders—Reply	38
JAMA Psychiatry	38
Error in Figure	38
Female Physician Suicide Compared to the General Population	38
Brain Morphometry Normative Modeling—Omit Global Thickness—Reply	37
Effect of Technology-Enhanced Screening in Addition to Standard Targeted Clinician Education on the Duration of Untreated Psychosis	37
Telehealth Mindfulness-Oriented Recovery Enhancement vs Usual Care in Individuals With Opioid Use Disorder and Pain	36
Understanding Placebo Mechanisms to Reduce Attrition in Psychiatric Trials	36
Mental Health Treatment Gap—The Implementation Problem as a Research Problem	36
Effects of a Smartphone-Based Self-management Intervention for Individuals With Bipolar Disorder on Relapse, Symptom Burden, and Quality of Life	36

Why Hippocampal Glutamate Levels Are Elevated in Schizophrenia	36
Association of Cardiovascular Health With Risk of Clinically Relevant Depressive Symptoms	35
RETRACTED: Dynamic Prediction of Outcomes for Youth at Clinical High Risk for Psychosis	35
COVID-19 and Risk for Mental Disorders Among Adults in Denmark	34
Functional Connectivity of the Nucleus Accumbens and Changes in Appetite in Patients With Depression	34
Differences in Insurance Coverage for Individuals With Schizophrenia After Implementation of the Patient Protection and Affordable Care Act	34
Issues With Person-Time and Repetitive Event Calculation	34
Written Exposure Therapy vs Prolonged Exposure Therapy in the Treatment of Posttraumatic Stress Disorder	34
Mental Health Care Support in Rural India	34
Substance Use Disorder and Health Outcomes in COVID-19—The Need for a Better Research Method to Determine Substance Use Exposure—Reply	34
Investing in a Research Workforce With Personal Experience of Serious Mental Illness	34
Substance Use Disorder and Health Outcomes in COVID-19—The Need for a Better Research Method to Determine Substance Use Exposure	33
COP27 Climate Change Conference—Urgent Action Needed for Africa and the World	33
Change to Open Access Status	33
Coding Error for the Sex Variable in a Meta-analysis	33
Lessons Learned From Drug Decriminalization Remedies in British Columbia	32
Data-Driven Contingency Management Incentive Magnitudes	32
Reporting and Representation of Race and Ethnicity in Clinical Trials of Pharmacotherapy for Mental Disorders	31
Antipsychotic Acute-Phase Treatment in Individuals With and Without Recent Treatment	31
Posttraumatic Stress Disorder, Obesity, and Accelerated Epigenetic Aging Among US Military Veterans	31
Association of 24-Hour Activity Pattern Phenotypes With Depression Symptoms and Cognitive Performance in Aging	31
Patterns of Brain Maturation in Autism and Their Molecular Associations	31
Alcohol Cue Processing in Co-Occurring Bipolar Disorder and Alcohol Use Disorder	31
International Variation in Clozapine Hematologic Monitoring—A Call for Action	31
Timing of Antidepressant Discontinuation During Pregnancy and Postpartum Psychiatric Outcomes in Denmark and Norway	30
Inflammatory Exposure and Depression in Older Adults With Insomnia	30
Representation and Outcomes of Individuals With Schizophrenia Seen in Everyday Practice Who Are Ineligible for Randomized Clinical Trials	30
Issues With Person-Time and Repetitive Event Calculation—Reply	30
Transcriptome-Wide Structural Equation Modeling of 13 Major Psychiatric Disorders for Cross-Disorder Risk and Drug Repurposing	30
Distinct Convergent Brain Alterations in Sleep Disorders and Sleep Deprivation	30
Association of Oxidative Stress–Induced Nucleic Acid Damage With Psychiatric Disorders in Adults	29
Preaddiction—A Missing Concept for Treating Substance Use Disorders	29
Effectiveness of Standard Sequential Bilateral Repetitive Transcranial Magnetic Stimulation vs Bilateral Theta Burst Stimulation in Older Adults With Depression	29
Interaction Testing and Polygenic Risk Scoring to Estimate the Association of Common Genetic Variants With Treatment Resistance in Schizophrenia	29
Inflammation and Brain Structure in Schizophrenia and Other Neuropsychiatric Disorders	29
Depression Associated With Hormonal Contraceptive Use as a Risk Indicator for Postpartum Depression	29
Estimated Number of Children Who Lost a Parent to Drug Overdose in the US From 2011 to 2021	29
Association of Brain Reward Response With Body Mass Index and Ventral Striatal-Hypothalamic Circuitry Among Young Women With Eating Disorders	29
Challenges to Behavioral Health and Injury Surveillance During the COVID-19 Pandemic—Reply	28
Long-term Arrhythmia Detection Using an Implantable Loop Recorder in Patients Receiving Psychotropic Medication	28
Dissimilar Control Interventions in Clinical Trials Undermine Interpretability—Reply	28
JAMA Psychiatry Editorial Fellow	28
Mental Health Service Use Before First Diagnosis of a Psychotic Disorder	27
JAMA Psychiatry Peer Reviewers in 2021	27
JAMA Psychiatry Editorial Fellow	27
Considerations in Publishing a Psychiatric Randomized Clinical Trial With Kenyan Children	27
Notice of Retraction: Worthington MA et al. Dynamic Prediction of Outcomes for Youth at Clinical High Risk for Psychosis: A Joint Modeling Approach. JAMA Psychiatry. 2023;80(10):1017-1025.	27
Error in Results and in the Figure 3B Label and Plotted Values	27
Neuropsychiatric Ramifications of Severe COVID-19 and Other Severe Acute Respiratory Infections	26
Psychopharmacologic Considerations for Transgender and Gender Diverse People	26
Maintenance of Wellness in Patients With Obsessive-Compulsive Disorder Who Discontinue Medication After Exposure/Response Prevention Augmentation	26
Clinical Outcomes of Magnetic Seizure Therapy vs Electroconvulsive Therapy for Major Depressive Episode	26
Suicidality Calls to a National Helpline After a Terror Attack and War	26
Treatment Outcomes With Licensed and Unlicensed Stimulant Doses for Adults With Attention-Deficit/Hyperactivity Disorder	26
Cognitive Function in People With Familial Risk of Depression	25
Clinician Suicide Risk Assessment for Prediction of Suicide Attempt in a Large Health Care System	25
Value-Based Payment and Behavioral Health	25
Evolutionary Inquiries Into the Origin and Nature of Mental Disorders	24
Social Disconnection as a Global Behavioral Epidemic—A Call to Action About a Major Health Risk Factor	24
Penetrance and Pleiotropy of Polygenic Risk Scores for Schizophrenia, Bipolar Disorder, and Depression Among Adults in the US Veterans Affairs Health Care System	24
Prevention of Incident and Recurrent Major Depression in Older Adults With Insomnia	24
Association Between Physical Activity and Risk of Depression	23
Error in Figure 2	23
SSRIs in Pregnancy—What Offspring Brain Volumes Can and Cannot Tell Us—Reply	23
JAMA Psychiatry	23
Antipsychotic Medications and Mortality in Children and Young Adults	23
Errors in Network Meta-Analysis of Generalized Anxiety Disorder Psychotherapies	23
Error in Figure Caption	23
Change to Open Access Status	23
An Atlas of Genetic Correlations and Genetically Informed Associations Linking Psychiatric and Immune-Related Phenotypes	23
Antidepressant Use and Manic Episodes in Children and Adolescents With Unipolar Depression	23
Transmission of Mental Disorders in Adolescent Peer Networks	22
Error in Display of Author Name	22
National Data on Age Gradients in Well-being Among US Adults	22
Grief-Specific Cognitive Behavioral Therapy vs Present-Centered Therapy	22
Polygenic Risk Scores Derived From Varying Definitions of Depression and Risk of Depression	22
Sleep Abnormalities in Different Clinical Stages of Psychosis	22
Addressing the Escalating Problems That Patients Encounter When Filling Buprenorphine Prescriptions	22
Years of Life Lost to Drug Overdose Among Black Female Individuals in the US, 2015-2021	22
Climate Events, Displacement, and Mental Health—Uprooted	22
Anorexia Nervosa—Facts, Frustrations, and the Future	22
Efficacy of Adjunctive D-Cycloserine to Intermittent Theta-Burst Stimulation for Major Depressive Disorder	22
Promoting Social Prescribing in Psychiatry—Using Shared Decision-Making and Peer Support	22
Esketamine Combined With SSRI or SNRI for Treatment-Resistant Depression	22
Potential of Control Conditions for Nonspecific Treatment Effects in Noninferiority Trials	22
Gratitude and Mortality Among Older US Female Nurses	22
Ten Practical Recommendations for Improving Blinding Integrity and Reporting in Psychotherapy Trials	22
Errors in Data Reported in Meta-Analysis on Opioid Agonist Treatment and Mortality	21
Beyond Voluntariness—Ethics and Incentives for Contraception	21
Youth-Initiated Mentoring as a Scalable Approach to Addressing Mental Health Problems During the COVID-19 Crisis	21
Overcoming the Scourge of Missing Data in Psychotherapy Trials	21
Error in Results	21
Association of Alcohol With Cortical Thickness in Adolescents	21
Preliminary Research Priorities for Factors Influencing Individual Outcomes for Users of the US National Suicide Prevention Lifeline	21
Effect of Exercise, Escitalopram, or Placebo on Anxiety in Patients With Coronary Heart Disease	21